Literature DB >> 11701645

Human population genetics: lessons from Finland.

J Kere1.   

Abstract

A population of about 5 million at the northern corner of Europe is unlikely to arouse the attention of the human genetics community, unless it offers something useful for others to learn. A combination of coincidences has finally made this population one that, out of proportion for its size, has by example shaped research in human disease genetics. This chapter summarizes advances made in medical genetics that are based on research facilitated by Finland's population structure. The annotation of the human genome for its polymorphism and involvement in disease is not over; it is, therefore, of interest to assess whether genetic studies in populations such as the Finnish might help in the remaining tasks.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11701645     DOI: 10.1146/annurev.genom.2.1.103

Source DB:  PubMed          Journal:  Annu Rev Genomics Hum Genet        ISSN: 1527-8204            Impact factor:   8.929


  24 in total

1.  Susceptibility loci for preeclampsia on chromosomes 2p25 and 9p13 in Finnish families.

Authors:  Hannele Laivuori; Päivi Lahermo; Vesa Ollikainen; Elisabeth Widen; Leena Häivä-Mällinen; Helena Sundström; Tarja Laitinen; Risto Kaaja; Olavi Ylikorkala; Juha Kere
Journal:  Am J Hum Genet       Date:  2002-12-09       Impact factor: 11.025

2.  Molecular and genealogical characterization of the R1443X BRCA1 mutation in high-risk French-Canadian breast/ovarian cancer families.

Authors:  Hélène Vézina; Francine Durocher; Martine Dumont; Louis Houde; Csilla Szabo; Martine Tranchant; Jocelyne Chiquette; Marie Plante; Rachel Laframboise; Jean Lépine; Heli Nevanlinna; Dominique Stoppa-Lyonnet; David Goldgar; Peter Bridge; Jacques Simard
Journal:  Hum Genet       Date:  2005-05-10       Impact factor: 4.132

3.  ELMOD2 is a candidate gene for familial idiopathic pulmonary fibrosis.

Authors:  Ulla Hodgson; Ville Pulkkinen; Morag Dixon; Myriam Peyrard-Janvid; Marko Rehn; Paivi Lahermo; Vesa Ollikainen; Kaisa Salmenkivi; Vuokko Kinnula; Juha Kere; Pentti Tukiainen; Tarja Laitinen
Journal:  Am J Hum Genet       Date:  2006-05-09       Impact factor: 11.025

4.  Subpopulation difference scanning: a strategy for exclusion mapping of susceptibility genes.

Authors:  E Salmela; O Taskinen; J K Seppänen; P Sistonen; M J Daly; P Lahermo; M-L Savontaus; J Kere
Journal:  J Med Genet       Date:  2006-01-27       Impact factor: 6.318

5.  Genetic markers and population history: Finland revisited.

Authors:  Jukka U Palo; Ismo Ulmanen; Matti Lukka; Pekka Ellonen; Antti Sajantila
Journal:  Eur J Hum Genet       Date:  2009-04-15       Impact factor: 4.246

6.  MAOA alters the effects of heavy drinking and childhood physical abuse on risk for severe impulsive acts of violence among alcoholic violent offenders.

Authors:  Roope Tikkanen; Francesca Ducci; David Goldman; Matti Holi; Nina Lindberg; Jari Tiihonen; Matti Virkkunen
Journal:  Alcohol Clin Exp Res       Date:  2010-03-01       Impact factor: 3.455

7.  Proportionally more deleterious genetic variation in European than in African populations.

Authors:  Kirk E Lohmueller; Amit R Indap; Steffen Schmidt; Adam R Boyko; Ryan D Hernandez; Melissa J Hubisz; John J Sninsky; Thomas J White; Shamil R Sunyaev; Rasmus Nielsen; Andrew G Clark; Carlos D Bustamante
Journal:  Nature       Date:  2008-02-21       Impact factor: 49.962

8.  Two functional variants of the superoxide dismutase genes in Finnish families with asthma.

Authors:  V L Kinnula; S Lehtonen; P Koistinen; S Kakko; M Savolainen; J Kere; V Ollikainen; T Laitinen
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

9.  Searching for Grendel: origin and global spread of the C9ORF72 repeat expansion.

Authors:  Hannah A Pliner; David M Mann; Bryan J Traynor
Journal:  Acta Neuropathol       Date:  2014-02-05       Impact factor: 17.088

10.  Epidemiology and characteristics of occipital brain infarcts in young adults in southwestern Finland.

Authors:  Mika H Martikainen; Kari Majamaa
Journal:  J Neurol       Date:  2010-02       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.